Education
M.D., Stanford University School of Medicine; M.P.H., Harvard T.H. Chan School of Public Health
Summary of Experience
Dr. Tsai is a surgeon and health policy expert, with a particular focus on improving the cost and quality of health care delivery in the US. His research spans questions related to hospital mergers, hospital governance and management, site of care optimization, value-based care payment models, and population health outcomes. Dr. Tsai’s clinical expertise is in surgical quality improvement and minimally invasive laparoscopic/robotic gastrointestinal and bariatric surgery. Additionally, he co-directs the Healthcare Quality and Outcomes Lab at the Harvard Chan School. From 2022 to 2023, Dr. Tsai served as senior policy advisor and Testing and Treatment Coordinator for the White House COVID-19 Response Team. In the latter position, he led federal testing and diagnostics initiatives and policies, including the COVIDtests.gov program and the national Test to Treat initiative. He has also been the director of Clinical Care Redesign at Brigham and Women’s Hospital, where he designed and implemented home hospital and other clinical innovation models for surgical patients. From 2014 to 2015, Dr. Tsai was the senior advisor to the Assistant Secretary for Planning and Evaluation in the US Department of Health and Human Services. He has also served as a technical expert or advisory committee member to the Centers for Medicare & Medicaid Services (CMS), the Health Resources and Services Administration (HRSA), and the Centers for Disease Control and Prevention (CDC). Dr. Tsai’s research has been published in numerous journals, including The New England Journal of Medicine, JAMA, PNAS, Nature Communications, Health Affairs, and the Annals of Surgery.
